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Abstract
Background: Despite significant advancement in breast cancer therapy, there is a great need for
a better understanding of the mechanisms involved in breast carcinogenesis and progression, as
well as of the role of epigenetic contributions from stromal cells in mammary tumorigenesis. In this
study, we isolated and characterized murine mammary tumor-derived epithelial and myofibroblast
cell lines, and investigated the in vitro and in vivo effect of cellular soluble factors produced by the
epithelial cell line on tumor cells.
Methods: Morphology, immunophenotype, cytogenetics, invasiveness, and tumorigenicity of
epithelial (LM-234ep) and myofibroblast (LM-234mf) cell lines isolated from two murine mammary
adenocarcinomas with common ancestor were studied. The in vitro effects of LM-234ep
conditioned medium on proliferation, cell cycle distribution, and expression of cell cycle proteins,
were investigated in LM-234mf cells, mouse melanoma cells (B16-F10), and human cervical
adenocarcinoma cells (HeLa). The in vivo anti-tumor activity of LM-234ep conditioned media was
evaluated in subcutaneous tumors formed in nude mice by B16-F10 and HeLa cells.
Results: LM-234ep cells were found to be cytokeratin positive and hipertriploid, whereas LM-
234mf cells were α-smooth muscle actin positive and hypohexaploid. Chromosome aberrations
were found in both cases. Only LM-234mf revealed to be invasive in vitro and to secrete active
MMP-2, though neither of the cell types were able to produce progressing tumors. LM-234ep-
derived factors were able to inhibit the in vitro growth of LM-234mf, B16-F10, and HeLa cells,
inducing cell cycle arrest in G0/G1 phase. The administration of LM-234ep conditioned medium
inhibited the growth of B16-F10 and HeLa tumors in nude mice.
Conclusion: Our data suggest the existence of epithelial cell variants with tumor suppressive
properties within mammary tumors. To our knowledge, this is the first report showing
antiproliferative and antineoplastic activities induced by tumor-derived epithelial cells.
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Breast cancer is the most frequent and the second deadli-
est neoplasm affecting females in the Western world [1].
Despite the enormous advancement in breast cancer ther-
apy in the last years, a better understanding of the mecha-
nisms involved in breast carcinogenesis and progression
may lead to novel therapies and increased patient sur-
vival.
For decades, processes involved in malignant transforma-
tion and progression have been ascribed only to genetic
alterations occurring in cells, with no influence of the sur-
rounding microenvironment where cells were located.
Because of this, most of the earlier studies were focused
exclusively on cancer cells. This concept changed over the
last years, as epigenetic contributions from stromal cells
in close proximity to cancer cells were found to play a cru-
cial role in the growth, angiogenesis, invasion, and metas-
tases of most carcinomas, including those originated in
breast [2-4]. In that aspect, the establishment and charac-
terization of cell lines derived not only from neoplastic
but also from stromal components of breast carcinomas
are extremely important to study more accurately the bio-
logical consequences of these heterotypic cell interactions.
Myofibroblasts, defined as fibroblasts with α-smooth
muscle actin (SMA) expression [5], constitute the most
predominant carcinoma-associated stromal cells, and
have been found to be involved in the production of dif-
ferent proteases responsible for invasion [6-8], as well as
in the stimulation of the proliferation of cancer cells
[9,10].
In the present study, we succeeded at isolating epithelial
(LM-234ep) and myofibroblast (LM-234mf) cell lines
from two murine mammary adenocarcinomas derived
from a common ancestor spontaneously arisen in BALB/c
mice [11]. Despite its malignant mammary carcinoma ori-
gin, the immortalized epithelial LM-234ep cell line was
not tumorigenic in either syngeneic or immunodepressed
mice. Moreover, the myofibroblast LM-234mf cell line
was more invasive in vitro than LM-234ep cell line. Para-
doxically, we found that LM-234ep-derived factors were
able not only to inhibit the proliferation of different can-
cer cells in vitro but also their growth in vivo. To our knowl-
edge, this is the first report showing antiproliferative and
antineoplastic activities induced by tumor-associated epi-
thelial cells.
Methods
Establishment of LM-234 cell lines
M-234 is a mammary tumor spontaneously arisen in a
BALB/c female mouse, histologically defined as a semidif-
ferentiated carcinoma with low mitotic rate, and absence
of estrogen and progesterone receptors [11]. The tumor,
obtained from the Animal Care Facility of School of Med-
ical Sciences, University of Rosario, is maintained by serial
subcutaneous passages in syngeneic mice. Two tumor var-
iants with similar characteristics obtained from M-234,
namely M-234p and M-234m, were used here. Non-
necrotic fragments from both tumors were used for in vitro
culture. Briefly, palpable tumors were aseptically excised,
and minced to about 1 mm3. The tumor pieces were dis-
aggregated by incubation at 37°C in phosphate buffered
saline (PBS) containing 0.25% bovine serum albumin
(BSA), 0.25% trypsin, 0.25% collagenase type II, and
0.1% hyaluronidase (all reagents from Sigma Chemical
Co., St. Louis, MO). The resulting cell suspensions were
centrifuged for 10 min at 1,000 rpm, and the pellets
obtained resuspended in RPMI-1640 or DMEM culture
media (Sigma) with 10% fetal bovine serum (FBS, Nato-
cor, Córdoba, Argentina). The cells derived from M-234p
grew faster in RPMI-1640 than in DMEM, whereas those
derived from M-234m grew only in DMEM. The cells have
been maintained in culture for over 60 passages. Cell lines
derived from M-234p and M-234m are referred to as LM-
234ep and LM-234mf, respectively.
Other cell lines
B16-F10, a C57BL/6 mouse melanoma cell line [12], and
HeLa, a human cervix adenocarcinoma cell line [13], were
both obtained from American Type Culture Collection
(ATCC, Manassas, VA). They were cultured in DMEM sup-
plemented with 10% FBS. BMA3.1A7 [14], a mouse mac-
rophage cell line derived from bone marrow, kindly
provided by Dr. Kenneth Rock (Dana-Farber Cancer Insti-
tute, Boston, MA), was cultured in RPMI 1640 with 10%
FBS. The osteoblast-like cell line 7F2 [15], isolated from
mouse bone marrow, was obtained from ATCC, and cul-
tured in Alpha minimum essential medium with 2 mM L-
glutamine, 1 mM sodium pyruvate without ribonucleo-
sides and deoxyribonucleosides, supplemented with 10%
FBS.
Immunocytochemistry and immunofluorescence analyses
LM-234ep and mf cells were grown overnight on sterile
13-mm Thermanox™ coverslips or Lab Tek™. 4-chamber
glass slides, both from Nunc (Naperville, IL). Cells were
rinsed in PBS, and then fixed in ice-cold methanol (-
20°C) for 30 min. After rinsing in PBS, immunoreactive
proteins were detected by one of three methods: 1) for
detection of SMA, slides were incubated with a fluores-
cein-conjugated monoclonal antibody that cross reacts
with human and mouse αSMA (20 µg/ml; Biomeda, Fos-
ter City, CA) for 1 h at room temperature, and then coun-
terstained with DAPI (Sigma, 5 µg/ml Tris buffer) for 20
sec, and mounted with Vectashield (Vector Laboratories,
Burlingame, USA); 2) for protein detection, slides were
incubated for 1 h at 37°C with a 1:200 antibody dilution
of mouse anti-c-Jun (Transduction Laboratories, San
Diego, CA), rabbit anti-cyclin A or rabbit anti-cyclin DPage 2 of 14
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then incubated for another hour with an anti-mouse or
rabbit FITC-antibody; 3) for detection of cytokeratin,
endogenous peroxidase activity was quenched with 3%
hydrogen peroxide in methanol, and non-specific immu-
nobinding blocked with Superblock (Scytek Laboratories,
Logan, UT) for 10 min at room temperature. Slides were
then incubated with an anti-Pan cytokeratin antibody
(1:50; Sigma) for 2 h at room temperature. After rinsing
with PBS, Vectastain Elite ABC kit for mouse IgG (Vector
Laboratories) was used. Immunoreactive cytokeratins
were recognized as a brown color after incubation with
diaminobenzidine (DAB; Sigma)/H2O2 solution. Slides
were lightly counterstained with Mayer hematoxylin
before mounting. For each epitope analyzed, species/iso-
type-matched pre-immune IgGs served as negative pri-
mary antibody controls.
Karyotyping
Exponentially growing LM-234ep and LM-234mf cell cul-
tures were exposed to 0.2 µg/ml colcemid (Sigma) for one
hour at 37°C. Metaphase spreads were prepared and
stained by conventional methods as described previously
[16]. A minimum of fifty metaphases for each cell line was
selected and photographed to determine chromosome
frequency distribution and morphology.
Zymography
Confluent monolayers of LM-234mf and LM-234ep cells
were incubated for 48 h in FBS-free culture media contain-
ing 0.1% BSA, to obtain conditioned media (CM). All CM
were cell number-normalized. The gelatinase activity was
detected by zymography in 10% sodium dodecyl sulfate-
polyacrylamide gels containing 1 mg/ml gelatin (Sigma),
as described previously [17]. Gelatinolytic bands were vis-
ualized as transparent areas against the dark-blue back-
ground. As positive controls for murine MMP-2 and
MMP-9, CM derived from 7F2 and BMA3.1A7 cell lines
were used, respectively.
Chemoinvasion assay
Cell invasion assay was carried out in Transwell® cell cul-
ture chambers (Corning Costar, Cambridge, Massachu-
setts) essentially as previously described [18]. Briefly, the
upper surface of the insert membrane (8-µm pore size)
was coated with 37.5 µg/100 µl of cold reconstituted base-
ment membrane Matrigel™, and dried overnight at room
temperature in a tissue culture hood. The lower compart-
ment of the Transwell® contained 5% FBS, which was used
as chemoattractant. LM-234ep or LM-234mf cells were
seeded at a density of 1 × 105per Transwell® culture insert
in 100 µl of DMEM containing 0.1% BSA. The chambers
were incubated at 37°C for 18 h. Non-migrating cells on
the upper surface of the filters were removed with a cotton
swab, whereas the cells that traversed the filters were
stained with Diff-Quick (Dade-Behring, Newark, DE),
and counted in 10 random 20× fields using a light micro-
scope. All the assays were carried out in triplicate.
Tumorigenic potential
Subconfluent LM-234ep and LM-234mf cell cultures were
trypsinized and resuspended in their respective FBS-free
culture medium. The viability of both cell types was above
90%, as determined by trypan blue exclusion. To test the
tumorigenicity of the cell lines, 1 × 106-1 × 107 cells were
subcutaneously or intramammary fat pad inoculated into
10–12 week-old female BALB/c (from the Rodent Facility
of the University of Rosario School of Medical Sciences)
or 8–12 week-old congenitally athymic female Swiss nude
mice (from the Mice Facility of Centro de Biología Molec-
ular Severo Ochoa, Universidad Autónoma de Madrid).
Co-inoculation of cells and Matrigel™ (BD Biosciences,
Rockville, MD), a basement membrane preparation
extracted from EHS mouse sarcoma, was performed in
some cases in an attempt to enhance tumorigenicity of the
cells [19]. To study the effect of heterotypic interaction on
tumor growth, experiments involving co-inoculation of
LM-234mf and LM-234ep cells (1.5 × 106 cells each) in
nude mice were performed. Tumors volumes were calcu-
lated as: π/6 × Length × Width × Height, based on periodic
measurement on calipers. Nude mice were maintained
under aseptic conditions.
Co-culture studies
LM-234ep and LM-234mf cells were seeded at 1:1 ratio
(104 cells for each cell line) onto Thermanox™ coverslips
that were placed inside 24-well tissue culture plates. Cells
were co-cultured in DMEM supplemented with 10% FBS,
and coverslips were harvested 4 and 8 days after cell seed-
ing for cytokeratin immunocytochemistry, performed as
explained above. Digital photomicrographs were cap-
tured using a Zeiss Axioplan 2 microscope (Zeiss, Göttin-
gen, Germany) equipped with a software-controlled
(Axiovision, Zeiss) digital camera.
Effect of conditioned media on cell proliferation
LM-234mf, B16-F10, and HeLa cells were seeded into 6-
well plates at a density of 1 × 104 cells/well on day 0, and
allowed to attach overnight. Thereafter, cells were incu-
bated in the presence of 1 ml of either LM-234ep or LM-
234mf CM, obtained after culturing confluent monolay-
ers for 48 h in their culture media containing 10% FBS, or
their respective complete culture medium (control). To
avoid non specific effect of the LM-234ep or LM-234mf
CM, the pH was controlled in all assays, the glucose, lac-
tate and glutamine were measured using a Biochemistry
analyzer YSI 2700 Select (YSI Inc., Yellow Springs, OH)
and we have used the same cell numbers of LM-234ep in
all the experiments to obtain the CM. Cell numbers werePage 3 of 14
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ber.
Fluorescence-activated cell sorting (FACS) analysis
After being exposed to LM-234ep CM or culture medium,
both supplemented with 10% FBS, LM-234mf, B16-F10,
and HeLa cells were harvested by trypsin digestion, resus-
pended in cold PBS, and fixed in 75% ethanol at 4°C for
at least 8 h. After a brief centrifugation, fixed cells were
resuspended in PBS containing propidium iodide (5 µg/
ml; Sigma)/RNase A (30 µg/ml, Sigma). After incubation
for 30 min at room temperature, DNA staining was evalu-
ated by fluorescence 2 intensity in the linear scale using
FACScan.
Immunoblotting
Cells were lysed on ice in lysis buffer (50 mM Tris-HCl
(pH 7.5), 300 mM NaCl, 0.5% Triton ×-100, 1 mM EDTA
and protease inhibitor). Cellular debris was removed by
centrifugation of lysates for 10 min at 14,000 g. The super-
natant was collected, and equal amounts of proteins, as
determined by the BCA protein micro assay (Bio-Rad Lab-
oratories, Hercules, CA), were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and
electroblotted onto nitrocellulose membranes. After the
transfer, membranes were blocked with a 10% (wt/vol)
solution of skim milk powder in PBS, and then probed
with one of the following primary antibodies: rabbit anti-
p-ERK (1:200; Santa Cruz Biotechnology), mouse anti-c-
Jun (1:1,000; Transduction Laboratories), rabbit anti-
JunB (1:500; Santa Cruz Biotechnology), rabbit anti-cyc-
lin E (1:200; Santa Cruz Biotechnology), rabbit anti-cyclin
A (1:200; Santa Cruz Biotechnology), rabbit anti-cyclin D
(1:200; Santa Cruz Biotechnology), mouse anti-Cdk2
(1:1,000; BD Transduction Laboratories), or rabbit anti-β-
actin (1:200, Sigma). The different antigens were detected
by chemiluminescence, using horseradish peroxidase-
conjugated antibody (1:500; Dako, Carpinteria, CA).
For immunodetection of cytokeratins, membranes were
incubated with a 1:500 dilution of monoclonal anti-pan
cytokeratin (Sigma), which recognizes cytokeratins 1, 4, 5,
6, 8, 10, 13, 18 and 19. The cytokeratins detected by these
antibodies range in molecular weight between 40 kDa
and 68 kDa. For immunodetection of αSMA a mono-
clonal antibody (clone 1A4, Sigma) was used at 1:200.
Measurement of AP-1 activity
Cells were transfected with the AP-1-luciferase reporter
gene plasmid carrying the collagenase promoter (p-73col-
luc) [20] or with the control plasmid without the AP-1 site
and the pRL-tk-luc plasmid (Promega, Madison, WI) to
normalize for transfection efficiency. After 24 h, the activ-
ity was determined using a Promega luciferase assay kit
following the manufacturer's protocol. Data were normal-
ized to Renilla luciferase activity and are presented in rela-
tive luciferase units. Transfections were always run in
triplicate and data presented as mean ± SD.
Treatment of tumor-bearing mice with LM-234ep 
conditioned medium
Nude mice were subcutaneously injected with 5 × 105 B16-
F10 or 1 × 106 HeLa cells in both flanks. Tumors were
allowed to grow until they became palpable, and then
locally injected with 200 µl of FBS-free LM-234ep CM in
the left flank, and with an equal volume of FBS-free cul-
ture medium contralaterally. Treatments were performed
once every 2 days in mice injected with B16-F10 cells, and
once a week in mice injected with HeLa cells. Treatments
were continued until tumors reached a median volume of
500 mm3. Five mice per group were used.
Histological analysis and immunohistochemistry
Tumors were fixed in 10% buffered formaldehyde, paraf-
fin-embedded, and processed by routine methods to get
5-µm consecutive histological sections that were used for
H&E staining and immunohistochemical studies. To
determine the proliferative activity within the tumors, sec-
tions were pretreated in Ag Citrus Plus Retrieval Solution
(BioGenex, San Ramon, CA) in a microwave, and then
incubated with anti-Ki67 monoclonal antibody (1:40;
BioGenex, San Ramon, CA). Intratumoral microvascular-
ity was assessed using a rat anti-mouse CD34 antibody
(1:25; Cell Sciences, Canton, MA). Mouse on Mouse
(MOM™) immunodetection peroxidase kit (Vector, Burl-
ingame, CA) and Vectastain Elite ABC kit for rat IgG (Vec-
tor Laboratories) were used to visualize Ki-67 and CD34
immunoreactive sites, respectively. Slides were lightly
counterstained with Mayer hematoxylin before mounting.
In each case, species/isotype-matched pre-immune IgGs
served as negative primary antibody controls.
Statistical analysis
Data were statistically analyzed using Student's t test using
GraphPad InStat® version 3.0 (GraphPad Software, San
Diego, CA). Differences were considered to be statistically
significant at P < 0.05.
Results
Morphology and immunophenotypic analysis
LM-234ep and LM-234mf cells grew in an adherent fash-
ion and have been maintained in culture for more than 60
passages. Their in vitro doubling time, calculated from the
logarithmic phase (days 1 to 5) of growth, was 25 h for
LM-234ep and 20 h for LM-234mf cells. Immunocyto-
chemical and immunofluorescence analysis for SMA and
cytokeratin showed that LM-234mf cells expressed SMA
but not cytokeratin (Figures 1A and 1B, respectively),
whereas LM-234ep cells expressed cytokeratin only (Fig-
ures 1C and 1D). These results, confirmed by immunob-Page 4 of 14
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exhibit characteristics of myofibroblasts, while LM-234ep
cells have an epithelial origin. From a morphological
point of view, LM-234mf cells were spindle-shaped,
revealing an intermediate phenotype between fibroblasts
and smooth muscle cells. Conversely, LM-234ep cells
were epitheloid.
Chromosome analysis
The cytogenetic analysis revealed aneuploidy for both cell
lines (Figures 2A and 2B). While the normal mouse kary-
otype consists of 40 acrocentric chromosomes, more than
60% of the LM-234ep cells showed between 61 and 70
chromosomes, with a modal number of 63 (Figure 2A). As
for LM-234mf cells, more than 70% of the cells had
Alpha smooth muscle actin (SMA) and cytokeratin expressionFigure 1
Alpha smooth muscle actin (SMA) and cytokeratin expression. SMA (green staining) was detected in LM-234mf (A) 
but not in LM-234ep (C) cells, using a FITC-conjugated primary antibody. Nuclei (blue staining) were identified using DAPI. 
Cytokeratin was undetectable in LM-234mf (B), whereas strongly expressed in LM-234ep (D), as revealed by immunohisto-
chemistry using an anti-Pan cytokeratin antibody. Magnification bar, 100 µm. Cell lysates (25 µg/lane) were analyzed using 
Western blot for cytokeratins (E) and αSMA (F). The cytokeratins detected with the anti-pan antibody used range between 40 
and 68 kDa. The band immunodetected for αSMA has an approximate molecular weight of 42 kDa. Glyceraldehyde 3-Phos-
phate Dehydrogenase (GAPDH) was used as a loading control.
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number of 111 (Figure 2B). The near-triploid (LM-234ep)
and near-hexaploid (LM-234mf) patterns shown might
result from endoreduplication/s occurred after some chro-
mosomal rearrangements. Chromosome aberrations
found in both cases include acentric fragments, chromo-
some breaks, and centromeric fusions (Figures 2C and
2D).
Differential in vitro gelatinase production and invasive 
capacities
FBS-free CM obtained from both cell types were analyzed
using gelatin zymography to determine whether MMP-2
and MMP-9 were produced and secreted as zymogens
and/or active species. As can be seen in Figure 3A, LM-
234mf cells secreted MMP-9 in its latent form, as well as
MMP-2 as zymogen and an intermediate active species
with higher molecular weight than the fully active MMP-
2. LM-234ep cells only secreted pro-MMP-2 in relatively
less amount than LM-234mf cells (Figure 3A). We also
used an in vitro reconstituted basement membrane inva-
sion assay to determine the invasive capacity of LM-234ep
and LM-234mf cells. We found that LM-234mf cells were
highly invasive, as opposed to the tumor-derived epithe-
lial LM-234ep cell line (Figure 3B). These results show a
clear association between expression of active MMP-2 and
invasiveness in these cell lines.
Tumorigenicity
The tumorigenic capacity of both LM-234 cell lines was
tested between passages 15 to 20 and between passages 45
to 50. Subcutaneous and intramammary fat pad inocula-
tions of 106, 5 × 106, and 107cells were performed in syn-
geneic BALB/c mice. LM-234ep cells were capable to
generate palpable growths that peaked by day 4 after inoc-
ulation of 107 cells, although their average median vol-
ume was only 5 mm3 and they regressed completely by
day 8. On the contrary, LM-234mf cells never gave rise to
Chromosome analysis of LM-234 cell linesFigure 2
Chromosome analysis of LM-234 cell lines. Histograms showing the chromosome number distribution in LM-234ep (A) 
and LM-234mf (B) cells. A minimum of 50 metaphase spreads was analyzed in each case. Representative metaphases of LM-
234ep (C) and LM-234mf (D) cells. Arrows point different chromosomal aberrations including: acentric fragments (1), chromo-
some break (2), and centromeric fusion (3). Magnification, × 1000.
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observation. The same results were obtained with both
cell lines when subcutaneously or intramammary fat pad
injected into nude mice, or co-inoculated with Matrigel™,
independently of the passage number (data not shown).
The effect of co-inoculation of LM-234mf and LM-234ep
cells on tumor growth was also measured. Four days after
inoculation, when tumescence peaked, volumes were
larger in mice co-injected with LM-234mf and LM-234ep
(33.6 ± 3.9 mm3) than in mice injected with LM-234ep
cells alone (4.9 ± 1.9 mm3). However, all the growths
regressed by day 12. Mice injected with LM-234mf cells
alone did not develop any growths.
Paracrine effects in crossover experiments
To study the effect of in vitro cell-cell interaction, LM-
234ep and LM-234mf cells were co-cultured at 1:1 ratio in
DMEM supplemented with 10% FBS. Four and eight days
after seeding, cells were immunostained for cytokeratin to
distinguish LM-234ep from LM-234mf cells. Despite
longer doubling time of LM-234ep cells, slower growth of
these cells when cultured in DMEM, and a similar distri-
bution of both cell types on day 4 (Figures 4A and 4B),
LM-234ep cells finally outgrew LM-234mf cells by day 8
(Figures 4C and 4D).
Crossover experiments, in which FBS-containing CM of
each of the cell lines was tested on the growth of the other
cell line, were also performed. Surprisingly, CM from LM-
234ep cells caused a significant inhibition of LM-234mf
cell growth, as opposed to LM-234mf CM, which did not
alter the growth curve of LM-234ep over a period of 7 days
(Figure 5A). FACS analysis of the cell cycle in LM-234mf
cells treated with LM-234ep CM, showed a significant
increase in the G0/G1 population, with a concomitant
decrease in the S phase and G2/M populations in all cases,
as compared with cells only treated with culture medium
(Figure 5B). Importantly, no apoptotic cells were found in
the subG0 phase of the cell cycle, which indicates that LM-
234ep CM induced cell growth arrest but not cell death.
These data support the results obtained in the co-culture
studies where cell-cell contact exists, and suggest an inhib-
itory effect of LM-234ep on LM-234mf.
The ERK/activating protein 1 (AP-1) pathway is impli-
cated in fundamental cellular processes including differ-
entiation, cell proliferation and oncogenic transformation
[21,22]. Since CM from LM-234ep cells caused inhibition
of LM-234mf cell growth, we analyzed the changes of p-
ERK and JunB/c-Jun proteins after the addition of the LM-
234ep CM in G0-synchronized and serum-stimulated LM-
234mf cells using Western blot. As shown in Figure 5C,
the levels of p-ERK and c-Jun were decreased in the cells
treated with LM-234ep CM, while JunB expression
remained unchanged. Immunofluorescence analyses con-
firmed the c-Jun inactivation (Figure 5D). We next ana-
lyzed AP-1 activity in LM-234mf cells upon LM-234ep CM
treatment using a reporter assay. Reduced levels of p-ERK/
c-Jun led to a significant decrease in AP-1 activity, as meas-
ured using a collagenase promoter reporter construct (Fig-
ure 5E). Previous data demonstrated that AP-1
inactivation induced down-regulation of cell cycle mole-
cules in breast cancer cells [23]. As compared to control
cells exposed to culture medium, LM-234mf cells incu-
bated with LM-234ep CM resulted in an evident densito-
metric decrease in the expression of cyclin A, D, and Cdk2,
whereas the expression of cyclin E did not change (Figures
5C). Reduction in Cyclin A and D expression was con-
firmed in the cells treated with LM-234ep CM by immun-
ofluorescence (Figures 5D).
Gelatinase expression/activity and invasive abilities of LM-234 cell linesFigur  3
Gelatinase expression/activity and invasive abilities of 
LM-234 cell lines. Conditioned media derived from LM-
234mf and LM-234ep cells were analyzed by gelatin zymogra-
phy, using 7F2 and BMA3.1A7 cell lines as positive controls 
for mouse MMP-2 and MMP-9, respectively (A). LM-234mf 
and ep cells were compared for their ability to invade 
through Matrigel-coated Transwell 8 µm-pore filters (B). The 
number of cells traversing the membrane was quantified and 
expressed as mean ± SE (n = 3).
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tumor cell lines
The effect of LM-234ep CM was also tested on the in vitro
proliferation of the mouse melanoma-derived B16-F10
cell line and the human cervix adenocarcinoma-derived
HeLa cell line. Cells were allowed to attach overnight, and
then incubated with FBS-containing CM from LM-234ep
and LM-234mf cells for 7 days. As can be seen in Figures
6A and 6C, a potent inhibition on the proliferation of
both cancer cell types was obtained after treatment with
LM-234ep CM despite the presence of growth factors in
FBS. Conversely, no significant inhibition on the prolifer-
ation of either of the tumor cell lines tested was observed
when LM-234mf CM was employed (Figures 6B and 6D).
The analysis of DNA content indicates that the prolifera-
tion arrest is also induced in the G0/G1 phase of the cell
cycle in these cells (Figure 7A). Reduction in the expres-
sion of cyclin A, D, E, and Cdk2 was observed in B16-F10
cells exposed to LM-234ep CM (Figure 7B), while a down-
regulated expression in cyclin A, D and E, and no change
in Cdk2, were detected in HeLa cells (Figures 7D).
Immunofluorescence analysis indicated a negative
nuclear localization of cyclin A in B16-F10 and HeLa cells
after LM-234ep CM treatment (Figure 7C and 7E). We also
tested the relevance of the estrogen receptor (ER) in the
cell arrest induced by the LM-234ep CM using ER+ (MCF-
7) or ER- (MDA-31) breast cancer cell lines. We found a
significant inhibition of the proliferation in both cell
types by LM-234ep CM but not by LM-234mf CM, sug-
gesting that the inhibitory effect shown by LM-234ep CM
is ER-independent (data not shown).
Inhibition of in vivo tumor growth by LM-234ep 
conditioned medium
Finally, we evaluated the effect of FBS-free conditioned
medium derived from LM-234ep cells on the in vivo
growth of B16-F10 or HeLa subcutaneous tumors in nude
mice. When tumors became palpable, local treatments
with FBS-free CM derived from LM-234ep cells (left flank)
and culture medium (right flank) were initiated. As soon
as 6 and 7 days after treatment began, a significant inhibi-
tion of growth was evident in B16-F10 (Figure 8A) and
HeLa (Figures 8B and 8C) tumors treated with LM-234ep
CM, as compared to contralateral tumors injected with
culture medium.
LM-234ep cells overgrow LM-234mf cellsFigure 4
LM-234ep cells overgrow LM-234mf cells. Cells were co-cultured at a 1:1 ratio and immunostained for cytokeratin on 
days 4 (A and B) and 8 (C and D) to distinguish LM-234ep (cytokeratin positive) from LM-234mf cells. Note the predominance 
of LM-234ep over LM-234mf cells on day 8. Magnification bar, 100 µm.
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Inhibitory effect of LM-234ep conditioned medium on the proliferation of LM-234mf cellsFigure 5
Inhibitory effect of LM-234ep conditioned medium on the proliferation of LM-234mf cells. LM-234mf and LM-
234ep cells were seeded into 6-well plates at a density of 1 × 104 cells/well and allowed to attach overnight. Thereafter, cells 
were incubated in the presence of LM-234ep CM (black circles), LM-234mf CM (black triangles), or culture medium (black 
squares) supplemented with 10% FBS. Cell numbers were counted at different time points, and expressed as mean ± SE. * P = 
0.05, ** P = 0.0018 (Student's t Test). Assays were performed in triplicate, (A). LM-234mf cells were incubated with culture 
medium + 10% FBS (Control) or LM-234ep CM for 72 h. Cells were processed for DNA content, and cell cycle progression 
was analyzed by flow cytometry (B). LM-234mf cells were treated with culture medium (Control) or LM-234ep CM for the 
times indicated (top). Cells were collected, lysed, and analyzed by immunoblotting using antibodies specific for p-ERK, c-Jun, 
JunB, cyclins E, A, and D, and Cdk2. β-actin was used as a loading control (C). Immunofluorescence for c-Jun, Cyclin A and 
Cyclin D in LM-234mf cells. The nuclear localization of the proteins is shown in the control cells (white arrows). Magnification 
bar, 40 µm (D). AP-1 luciferase activity in LM-234mf cells co-transfected with AP-1-Luc and pRL-tk-luc and treated with LM-
234ep CM or culture medium (Control). ** P = 0.005 (Student's t Test). The results shown are the mean ± S.D. of three 
experiments (E).
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sections using CD34 immunostaining. Microvessel densi-
ties per 20× field in hot spots were similar in HeLa tumors
treated with LM-234ep CM and regular culture medium
(28.8 ± 3.3 and 28.2 ± 4.2 CD34+ structures, respectively).
However, immunohistochemical staining of the tissue
sections by Ki-67 revealed a significant lower proliferation
index in LM-234ep CM-treated than in culture medium-
treated tumors (361.5 ± 28.0 and 474.3 ± 27.0 Ki67+
cells/mm2, respectively, P < 0.05). Similar results were
found in B16-F10 tumors growing in nude mice following
the same treatment. These results suggest that the antine-
oplastic effect of LM-234ep CM is due to a direct antipro-
liferative effect on the tumor cells rather than to an
inhibition of their angiogenesis.
Discussion
For many decades, the neoplastic phenotype has been
considered to be driven only by genetic alterations occur-
ring in cells. However, many studies performed in the last
years have demonstrated that genetic changes in individ-
ual cells may not be sufficient, and that the cellular micro-
environment has a powerful influence in determining the
final fate of cells in the process of transformation [24-26].
The oncogenic potential of cells can be modulated by
adjacent cells in opposite directions, sometimes contrib-
uting to tumor formation [4,27] and others impeding it
[28,29]. Moreover, stromal cells present in the tumor
microenvironment have a profound effect on tumor
growth, invasion and metastatic progression [30]. This is
also true for breast cancer, where most of the studies have
focused on the luminal epithelial cells found in the ducts
and alveoli, despite the presence of stromal cells including
fibroblasts, myofibroblasts, leukocytes, and myoepithe-
lial cells [4,27]. Myofibroblasts, for instance, which are
usually absent in normal tissue derived from breast, have
been associated with tumor progression [26,31].
To attain a better understanding of the complex hetero-
typic interactions that occur in breast cancer, suitable
model systems should involve cells representing both epi-
thelial and stromal cells ideally derived from mammary
tumors. Here, we isolated and established two cell lines
from mammary carcinomas derived from a common
tumor spontaneously arisen in a BALB/c female mouse
[11]. On the basis of their immunophenotypical features,
the cytokeratin positive and SMA negative LM-234ep cell
line was considered of epithelial origin, whereas LM-
234mf, which is positive for SMA but lacks cytokeratin
expression, was categorized as myofibroblast. Both cell
lines have been growing in culture for over 60 passages,
with abnormalities in the number and structure of their
chromosomes. In the near-triploid LM-234ep cells, dou-
ble-minutes are found, suggesting genomic amplification.
As for the near-hexaploid LM-234mf cells, mostly chro-
mosomes breaks are observed. Despite these features char-
acteristic of cancerous cells, both cell lines did not
generate progressing tumors mice when different num-
bers of cells were injected subcutaneously (with or with-
out Matrigel) or orthotopically in the mammary fat pad of
either syngeneic mice or nude mice. Due to their epithelial
phenotype, their immortalized nature, and the fact that
they were derived from a mammary tumor, LM-234ep
cells appear to derive from carcinoma cells, though they
only revealed an incipient growth in vivo that did not per-
sist. Although some ER positive breast cancer cells do not
form tumors unless the hosts are treated with β-estradiol,
that would not be the case for LM-234ep cells that are ER
negative (data not shown). As for LM-234mf myofibrob-
last cells, it is not clear why they escaped from senescence
and revealed anomalous chromosome patterns usually
present in cancerous cells, but did not induce tumor for-
mation. These results agree with those obtained in an
immortalized myofibroblast cell line obtained from a
human liver angiosarcoma, which also shows severe chro-
mosomal alterations and inability to induce tumors [32].
Particularly in breast cancer, where epithelial-mesenchy-
mal transition occurs in approximately 18% of tumors
[33], a transdifferentiation of epithelial tumor cells into
myofibroblasts that lose their malignant phenotype has
been reported [34]. We hypothesize that this could have
been the case for LM-234mf myofibroblasts, which are
LM-234ep conditioned medium inhibits cell proliferation in cancer cellsFigure 6
LM-234ep conditioned medium inhibits cell prolifera-
tion in cancer cells. B16-F10 (A and B), or HeLa (C and D) 
cells were seeded into 6-well plates at a density of 1 × 104 
cells/well and allowed to attach overnight. Cells were incu-
bated with LM-234ep CM (black circles), LM-234mf CM 
(black triangles), or culture medium (black squares) contain-
ing 10% FBS (Control), and counted at different time points. 
Data are shown as mean ± SE. * P = 0.05, ** P = 0.0018, *** P 
= 0.0006, **** P < 0.0001 (Student's t Test). Assays were 
performed in triplicate.
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Effects of LM-234ep conditioned medium on cell cycle and its regulatory proteinsFigure 7
Effects of LM-234ep conditioned medium on cell cycle and its regulatory proteins. B16-F10 and HeLa cells were 
treated with culture medium (Control) or LM-234ep CM for 48 h. Cell cycle progression was analyzed by flow cytometry (A). 
After the treatment for the indicated times (top) with LM-234ep CM or culture medium (Control), B16-F10 (B) and HeLa (D) 
cells were collected, lysed, and analyzed by immunoblotting using antibodies specific for cyclins E, A, and D, and Cdk2. β-actin 
was used as a loading control. Immunofluorescence for Cyclin A1 in B16-F10 (C), and HeLa (E) cells after 24 h incubation with 
culture medium or LM-234ep CM. Magnification bar, 40 µm.
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cancer cells. In fact, myofibroblasts are considered a
desmoplastic reaction that may facilitate mammary tumor
growth and invasion [34]. Myofibroblasts, for example,
can invade certain tumors preceding endothelial invasion
necessary for angiogenesis [35,36]. Here, we show that
LM-234mf cells are highly invasive in vitro and secrete
MMP-2 in an active form, whereas epithelial LM-234ep
cells are almost non invasive and only secrete MMP-2 as a
zymogen.
It is now widely accepted that a concerted action of epithe-
lial and stromal cells is necessary to support tumor growth
and progression. Having two different cell types derived
from murine mammary tumors of common origin, we
aimed at elucidating the impact of their heterotypic inter-
action on tumor growth. As we mentioned above, only
LM-234ep cells induced a small and brief tumescence in
vivo that then regressed. Despite an enhanced growth
obtained when LM-234mf and LM-234ep cells were co-
inoculated in nude mice, this ended up in a complete
regression. When both cell types were co-cultured, a pre-
dominance of LM-234ep over LM-234mf was evident.
This cannot be explained in terms of different growth
rates, as LM-234ep cells have a longer doubling time than
LM-234mf cells. Taken together, our results suggests an
inhibitory effect of LM-234ep on LM-234mf cells, and
could explain why the initial enhancing effect revealed by
LM-234mf on LM-234ep cell growth in vivo was finally
hampered by the epithelial cell type. This inhibitory effect
displayed by LM-234ep cells would be accomplished by
diffusible factors, since LM-234ep CM revealed strong
inhibitory activity in vitro on LM-234mf cell proliferation,
which would be mediated by down-regulation of the
ERK/AP-1 pathway. The antiproliferative effect was also
observed on a mouse melanoma cell line (B16-F10) and
Inhibition of in vivo tumor growth by LM-234ep conditioned mediumFigure 8
Inhibition of in vivo tumor growth by LM-234ep conditioned medium. B16-F10 (A) and HeLa (B) tumors growing in 
the right flank were injected with serum-free culture medium (black squares), whereas tumors in the left flank were injected 
with LM-234ep CM (black triangles). Tumors were measured and volumes were calculated as mean ± SE. * P = 0.018, ** P = 
0.007, *** P = 0.004 (Student's t Test). Representative picture of a mouse showing inhibition of HeLa tumor growth by LM-
234ep CM (arrow) as compared to culture medium treatment (contralateral flank), 4 weeks after tumor inoculation (C).
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cases, is the result of an arrest of the cells at the G0/G1
phase of the cell cycle. The reduced levels of cyclins E, A,
and D, and of Cdk2 would account for the observed
decrease in the percentage of cells in the S-G2/M phase.
These results suggest that the inhibitory factor(s) derived
from LM-234ep cells can directly or indirectly down-regu-
late the expression of those cell cycle genes. Moreover, the
growth of tumors formed in nude mice by injection of
HeLa and B16-F10 cells was inhibited by local treatment
with LM-234ep CM. The immunohistochemical analysis
of the nuclear Ki67 proliferation marker suggests an anti-
proliferative direct effect on the tumor cells.
Different studies have demonstrated that the normal
myoepithelium can function as an inhibitor of growth,
angiogenesis, invasion, and metastasis of breast cancer
cells [37-40]. However, to the best of our knowledge,
there are no reports on growth inhibitory activity of solu-
ble factors derived from tumor-associated epithelial cells.
Our results suggest that within the highly heterogeneous
mammary tumor cell populations there are epithelial cells
acting as guardians that may counterbalance malignant
progression through antiproliferative effects. Further stud-
ies are currently in progress to enlighten the nature of the
factor(s) produced by tumor-derived LM-234ep that are
responsible for the inhibitory effect demonstrated on
tumors.
Conclusion
The results herein obtained indicate that LM-234ep and
LM-234mf cell lines are suitable models to examine sev-
eral aspects of tumor biology, in particular those related to
the different pathways involved in the genetic events lead-
ing to tumor generation. We consider both cell lines as
transformed but non tumorigenic. Also, as these cell lines
are neither normal nor malignant, and can be situated
somewhere in between those two stages, they could be
used as a model to study different therapeutic strategies
aiming to revert the transformed immortal cell type to a
normal senescent one.
More interestingly, our data suggest the existence of epi-
thelial cells with tumor-inhibitory activity within mam-
mary tumors. The LM-234ep cell line characterized here
would exemplify such cells that are transformed, as they
displayed several chromosomal anomalies and did not
senesce when cultured in vitro, and could represent a pro-
tective mechanism against tumor progression. The broad
inhibitory spectrum activity demonstrated by the factor(s)
secreted by LM-234ep cells on the in vitro proliferation
and the in vivo growth of two non-related tumors justifies
further studies that could derive in a novel therapeutic
option for cancer.
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